tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JP:4882 Stock Latest News

Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
Company AnnouncementsPerseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
4d ago
4882
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
PremiumCompany Announcements
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
4d ago
4882
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
PremiumCompany Announcements
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
3M ago
4882
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
PremiumCompany Announcements
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
3M ago
4882
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
PremiumCompany Announcements
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
3M ago
4882
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
PremiumCompany AnnouncementsPerseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
3M ago
4882
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
Premium
Company Announcements
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
6M ago
4882
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
Premium
Company Announcements
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
6M ago
4882
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
PremiumCompany Announcements
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
9M ago
4882
Perseus Proteomics Inc. Announces Change in Accounting Auditor
PremiumCompany Announcements
Perseus Proteomics Inc. Announces Change in Accounting Auditor
9M ago
4882
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
PremiumCompany Announcements
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
9M ago
4882
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
PremiumCompany Announcements
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
11M ago
4882
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
PremiumCompany AnnouncementsPerseus Proteomics Completes Phase I Trial Report for PPMX-T003
11M ago
4882
Perseus Proteomics Updates PPMX-T003 Project Details
Premium
Company Announcements
Perseus Proteomics Updates PPMX-T003 Project Details
12M ago
4882
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
Premium
Company Announcements
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
12M ago
4882
Perseus Proteomics Reports Financial Adjustments and Losses
PremiumCompany Announcements
Perseus Proteomics Reports Financial Adjustments and Losses
1y ago
4882
Perseus Proteomics Reports Increased Sales but Continued Losses
PremiumCompany Announcements
Perseus Proteomics Reports Increased Sales but Continued Losses
1y ago
4882
Perseus Proteomics Extends Clinical Trial for Rare Leukemia
PremiumCompany Announcements
Perseus Proteomics Extends Clinical Trial for Rare Leukemia
1y ago
4882
Perseus Proteomics Reports Promising Trial Results
PremiumCompany Announcements
Perseus Proteomics Reports Promising Trial Results
1y ago
4882
Perseus Proteomics Faces Mixed Financial Results
PremiumCompany AnnouncementsPerseus Proteomics Faces Mixed Financial Results
1y ago
4882
Perseus Proteomics to Present Antibody Trial Results
Premium
Company Announcements
Perseus Proteomics to Present Antibody Trial Results
1y ago
4882
Perseus Proteomics Unveils Promising Cancer Treatment
Premium
Company Announcements
Perseus Proteomics Unveils Promising Cancer Treatment
1y ago
4882

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >